Alliance for Multispecialty Research in Knoxville, TN. is currently seeking volunteers ages 18-55 for a COVID-19 clinical research study.
This is a phase 2 study to evaluate the safety, tolerability, and immunogenicity of SARS-CoV-2 RNA vaccine following prior receipt of the Johnson & Johnson COVID-19 vaccine.
We are looking for volunteers who have recently received or plan on getting the Johnson & Johnson (J&J) one dose vaccine in the next week or so.
In addition, we will be taking a small number of patients that have never received a prior COVID-19 vaccine.
Volunteers will receive two doses of the vaccine or placebo and make up to 7 visits to the study center over 6 months. Compensation of $1,225 will be available for time and travel.
All participants will receive a booster dose with the same BNT162b2 vaccine used during the study approximately 6 months after the study series.
To participate:
Be between the ages of: 18 - 55
Have no autoimmune conditions
Have a BMI between: 18 - 32
Have no bleeding disorders or be taking any blood thinners
Have no current Cancer diagnosis
Have no previous diagnosis of COVID-19
Please call for additional inclusion/exclusion criteria
For more information, or to learn if you qualify, call us at 865-305-DRUG (3784) or visit www.volresearch.com
*This study will be held at our 801 N. Weisgarber Rd., Suite 100 location*
Discussion
By posting you agree to the Terms and Privacy Policy.